Global Organ Transplant Immunosuppressant Market Growth 2020-2025
According to this study, over the next five years the Organ Transplant Immunosuppressant market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Organ Transplant Immunosuppressant business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Organ Transplant Immunosuppressant market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Organ Transplant Immunosuppressant, covering the supply chain analysis, impact assessment to the Organ Transplant Immunosuppressant market size growth rate in several scenarios, and the measures to be undertaken by Organ Transplant Immunosuppressant companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Tacrolimus
Mycophenolate Mofetil
Cyclosporin
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Liver Transplant
Kidney Transplant
Heart Transplant
Other Organ Transplant
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
North China Pharmaceutical Group Corporation
Astellas Pharma Inc.
Novartis
Catalent Pharma
Huadong Pharmaceutical
Genzyme
Cinkate Corporation
Changzhou Pharm
Cilag
SL PHARM
Sirio Pharma Co., Ltd
Livzon Pharmaceutical Group Inc.,
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Organ Transplant Immunosuppressant consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Organ Transplant Immunosuppressant market by identifying its various subsegments.
Focuses on the key global Organ Transplant Immunosuppressant manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Organ Transplant Immunosuppressant with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Organ Transplant Immunosuppressant submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Organ Transplant Immunosuppressant Consumption 2015-2025
2.1.2 Organ Transplant Immunosuppressant Consumption CAGR by Region
2.2 Organ Transplant Immunosuppressant Segment by Type
2.2.1 Tacrolimus
2.2.2 Mycophenolate Mofetil
2.2.3 Cyclosporin
2.2.4 Others
2.3 Organ Transplant Immunosuppressant Consumption by Type
2.3.1 Global Organ Transplant Immunosuppressant Consumption Market Share by Type (2015-2020)
2.3.2 Global Organ Transplant Immunosuppressant Revenue and Market Share by Type (2015-2020)
2.3.3 Global Organ Transplant Immunosuppressant Sale Price by Type (2015-2020)
2.4 Organ Transplant Immunosuppressant Segment by Application
2.4.1 Liver Transplant
2.4.2 Kidney Transplant
2.4.3 Heart Transplant
2.4.4 Other Organ Transplant
2.5 Organ Transplant Immunosuppressant Consumption by Application
2.5.1 Global Organ Transplant Immunosuppressant Consumption Market Share by Type (2015-2020)
2.5.2 Global Organ Transplant Immunosuppressant Value and Market Share by Type (2015-2020)
2.5.3 Global Organ Transplant Immunosuppressant Sale Price by Type (2015-2020)
3 Global Organ Transplant Immunosuppressant by Company
3.1 Global Organ Transplant Immunosuppressant Sales Market Share by Company
3.1.1 Global Organ Transplant Immunosuppressant Sales by Company (2018-2020)
3.1.2 Global Organ Transplant Immunosuppressant Sales Market Share by Company (2018-2020)
3.2 Global Organ Transplant Immunosuppressant Revenue Market Share by Company
3.2.1 Global Organ Transplant Immunosuppressant Revenue by Company (2018-2020)
3.2.2 Global Organ Transplant Immunosuppressant Revenue Market Share by Company (2018-2020)
3.3 Global Organ Transplant Immunosuppressant Sale Price by Company
3.4 Global Organ Transplant Immunosuppressant Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Organ Transplant Immunosuppressant Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Organ Transplant Immunosuppressant Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Organ Transplant Immunosuppressant by Regions
4.1 Organ Transplant Immunosuppressant by Regions
4.2 Americas Organ Transplant Immunosuppressant Consumption Growth
4.3 APAC Organ Transplant Immunosuppressant Consumption Growth
4.4 Europe Organ Transplant Immunosuppressant Consumption Growth
4.5 Middle East & Africa Organ Transplant Immunosuppressant Consumption Growth
5 Americas
5.1 Americas Organ Transplant Immunosuppressant Consumption by Countries
5.1.1 Americas Organ Transplant Immunosuppressant Consumption by Countries (2015-2020)
5.1.2 Americas Organ Transplant Immunosuppressant Value by Countries (2015-2020)
5.2 Americas Organ Transplant Immunosuppressant Consumption by Type
5.3 Americas Organ Transplant Immunosuppressant Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Organ Transplant Immunosuppressant Consumption by Regions
6.1.1 APAC Organ Transplant Immunosuppressant Consumption by Regions (2015-2020)
6.1.2 APAC Organ Transplant Immunosuppressant Value by Regions (2015-2020)
6.2 APAC Organ Transplant Immunosuppressant Consumption by Type
6.3 APAC Organ Transplant Immunosuppressant Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Organ Transplant Immunosuppressant by Countries
7.1.1 Europe Organ Transplant Immunosuppressant Consumption by Countries (2015-2020)
7.1.2 Europe Organ Transplant Immunosuppressant Value by Countries (2015-2020)
7.2 Europe Organ Transplant Immunosuppressant Consumption by Type
7.3 Europe Organ Transplant Immunosuppressant Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Organ Transplant Immunosuppressant by Countries
8.1.1 Middle East & Africa Organ Transplant Immunosuppressant Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Organ Transplant Immunosuppressant Value by Countries (2015-2020)
8.2 Middle East & Africa Organ Transplant Immunosuppressant Consumption by Type
8.3 Middle East & Africa Organ Transplant Immunosuppressant Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Organ Transplant Immunosuppressant Distributors
10.3 Organ Transplant Immunosuppressant Customer
11 Global Organ Transplant Immunosuppressant Market Forecast
11.1 Global Organ Transplant Immunosuppressant Consumption Forecast (2021-2025)
11.2 Global Organ Transplant Immunosuppressant Forecast by Regions
11.2.1 Global Organ Transplant Immunosuppressant Forecast by Regions (2021-2025)
11.2.2 Global Organ Transplant Immunosuppressant Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Organ Transplant Immunosuppressant Forecast by Type
11.8 Global Organ Transplant Immunosuppressant Forecast by Application
12 Key Players Analysis
12.1 Roche
12.1.1 Company Information
12.1.2 Organ Transplant Immunosuppressant Product Offered
12.1.3 Roche Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Roche Latest Developments
12.2 North China Pharmaceutical Group Corporation
12.2.1 Company Information
12.2.2 Organ Transplant Immunosuppressant Product Offered
12.2.3 North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 North China Pharmaceutical Group Corporation Latest Developments
12.3 Astellas Pharma Inc.
12.3.1 Company Information
12.3.2 Organ Transplant Immunosuppressant Product Offered
12.3.3 Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Astellas Pharma Inc. Latest Developments
12.4 Novartis
12.4.1 Company Information
12.4.2 Organ Transplant Immunosuppressant Product Offered
12.4.3 Novartis Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Novartis Latest Developments
12.5 Catalent Pharma
12.5.1 Company Information
12.5.2 Organ Transplant Immunosuppressant Product Offered
12.5.3 Catalent Pharma Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Catalent Pharma Latest Developments
12.6 Huadong Pharmaceutical
12.6.1 Company Information
12.6.2 Organ Transplant Immunosuppressant Product Offered
12.6.3 Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Huadong Pharmaceutical Latest Developments
12.7 Genzyme
12.7.1 Company Information
12.7.2 Organ Transplant Immunosuppressant Product Offered
12.7.3 Genzyme Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Genzyme Latest Developments
12.8 Cinkate Corporation
12.8.1 Company Information
12.8.2 Organ Transplant Immunosuppressant Product Offered
12.8.3 Cinkate Corporation Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Cinkate Corporation Latest Developments
12.9 Changzhou Pharm
12.9.1 Company Information
12.9.2 Organ Transplant Immunosuppressant Product Offered
12.9.3 Changzhou Pharm Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Changzhou Pharm Latest Developments
12.10 Cilag
12.10.1 Company Information
12.10.2 Organ Transplant Immunosuppressant Product Offered
12.10.3 Cilag Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Cilag Latest Developments
12.11 SL PHARM
12.11.1 Company Information
12.11.2 Organ Transplant Immunosuppressant Product Offered
12.11.3 SL PHARM Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 SL PHARM Latest Developments
12.12 Sirio Pharma Co., Ltd
12.12.1 Company Information
12.12.2 Organ Transplant Immunosuppressant Product Offered
12.12.3 Sirio Pharma Co., Ltd Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Sirio Pharma Co., Ltd Latest Developments
12.13 Livzon Pharmaceutical Group Inc.,
12.13.1 Company Information
12.13.2 Organ Transplant Immunosuppressant Product Offered
12.13.3 Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Livzon Pharmaceutical Group Inc., Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Organ Transplant Immunosuppressant Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Tacrolimus
Table 5. Major Players of Mycophenolate Mofetil
Table 6. Major Players of Cyclosporin
Table 7. Major Players of Others
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Organ Transplant Immunosuppressant Consumption Market Share by Type (2015-2020)
Table 10. Global Organ Transplant Immunosuppressant Revenue by Type (2015-2020) ($ million)
Table 11. Global Organ Transplant Immunosuppressant Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Organ Transplant Immunosuppressant Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Organ Transplant Immunosuppressant Consumption Market Share by Application (2015-2020)
Table 15. Global Organ Transplant Immunosuppressant Value by Application (2015-2020)
Table 16. Global Organ Transplant Immunosuppressant Value Market Share by Application (2015-2020)
Table 17. Global Organ Transplant Immunosuppressant Sale Price by Application (2015-2020)
Table 18. Global Organ Transplant Immunosuppressant Sales by Company (2017-2019) (K Units)
Table 19. Global Organ Transplant Immunosuppressant Sales Market Share by Company (2017-2019)
Table 20. Global Organ Transplant Immunosuppressant Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Organ Transplant Immunosuppressant Revenue Market Share by Company (2017-2019)
Table 22. Global Organ Transplant Immunosuppressant Sale Price by Company (2017-2019)
Table 23. Global Organ Transplant Immunosuppressant Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Organ Transplant Immunosuppressant Products Offered
Table 25. Organ Transplant Immunosuppressant Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Organ Transplant Immunosuppressant Consumption by Regions 2015-2020 (K Units)
Table 27. Global Organ Transplant Immunosuppressant Consumption Market Share by Regions 2015-2020
Table 28. Global Organ Transplant Immunosuppressant Value by Regions 2015-2020 ($ Millions)
Table 29. Global Organ Transplant Immunosuppressant Value Market Share by Regions 2015-2020
Table 30. Americas Organ Transplant Immunosuppressant Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Organ Transplant Immunosuppressant Consumption Market Share by Countries (2015-2020)
Table 32. Americas Organ Transplant Immunosuppressant Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Organ Transplant Immunosuppressant Value Market Share by Countries (2015-2020)
Table 34. Americas Organ Transplant Immunosuppressant Consumption by Type (2015-2020) (K Units)
Table 35. Americas Organ Transplant Immunosuppressant Consumption Market Share by Type (2015-2020)
Table 36. Americas Organ Transplant Immunosuppressant Consumption by Application (2015-2020) (K Units)
Table 37. Americas Organ Transplant Immunosuppressant Consumption Market Share by Application (2015-2020)
Table 38. APAC Organ Transplant Immunosuppressant Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Organ Transplant Immunosuppressant Consumption Market Share by Countries (2015-2020)
Table 40. APAC Organ Transplant Immunosuppressant Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Organ Transplant Immunosuppressant Value Market Share by Regions (2015-2020)
Table 42. APAC Organ Transplant Immunosuppressant Consumption by Type (2015-2020) (K Units)
Table 43. APAC Organ Transplant Immunosuppressant Consumption Market Share by Type (2015-2020)
Table 44. APAC Organ Transplant Immunosuppressant Consumption by Application (2015-2020) (K Units)
Table 45. APAC Organ Transplant Immunosuppressant Consumption Market Share by Application (2015-2020)
Table 46. Europe Organ Transplant Immunosuppressant Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Organ Transplant Immunosuppressant Consumption Market Share by Countries (2015-2020)
Table 48. Europe Organ Transplant Immunosuppressant Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Organ Transplant Immunosuppressant Value Market Share by Countries (2015-2020)
Table 50. Europe Organ Transplant Immunosuppressant Consumption by Type (2015-2020) (K Units)
Table 51. Europe Organ Transplant Immunosuppressant Consumption Market Share by Type (2015-2020)
Table 52. Europe Organ Transplant Immunosuppressant Consumption by Application (2015-2020) (K Units)
Table 53. Europe Organ Transplant Immunosuppressant Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Organ Transplant Immunosuppressant Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Organ Transplant Immunosuppressant Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Organ Transplant Immunosuppressant Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Organ Transplant Immunosuppressant Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Organ Transplant Immunosuppressant Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Organ Transplant Immunosuppressant Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Organ Transplant Immunosuppressant Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Organ Transplant Immunosuppressant Consumption Market Share by Application (2015-2020)
Table 62. Organ Transplant Immunosuppressant Distributors List
Table 63. Organ Transplant Immunosuppressant Customer List
Table 64. Global Organ Transplant Immunosuppressant Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Organ Transplant Immunosuppressant Consumption Market Forecast by Regions
Table 66. Global Organ Transplant Immunosuppressant Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Organ Transplant Immunosuppressant Value Market Share Forecast by Regions
Table 68. Global Organ Transplant Immunosuppressant Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Organ Transplant Immunosuppressant Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Organ Transplant Immunosuppressant Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Organ Transplant Immunosuppressant Value Market Share Forecast by Type (2021-2025)
Table 72. Global Organ Transplant Immunosuppressant Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Organ Transplant Immunosuppressant Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Organ Transplant Immunosuppressant Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Organ Transplant Immunosuppressant Value Market Share Forecast by Application (2021-2025)
Table 76. Roche Product Offered
Table 77. Roche Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. Roche Main Business
Table 79. Roche Latest Developments
Table 80. Roche Basic Information, Company Total Revenue (in $ million), Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 81. North China Pharmaceutical Group Corporation Product Offered
Table 82. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. North China Pharmaceutical Group Corporation Main Business
Table 84. North China Pharmaceutical Group Corporation Latest Developments
Table 85. North China Pharmaceutical Group Corporation Basic Information, Company Total Revenue (in $ million), Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 86. Astellas Pharma Inc. Product Offered
Table 87. Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. Astellas Pharma Inc. Main Business
Table 89. Astellas Pharma Inc. Latest Developments
Table 90. Astellas Pharma Inc. Basic Information, Company Total Revenue (in $ million), Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 91. Novartis Product Offered
Table 92. Novartis Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. Novartis Main Business
Table 94. Novartis Latest Developments
Table 95. Novartis Basic Information, Company Total Revenue (in $ million), Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 96. Catalent Pharma Product Offered
Table 97. Catalent Pharma Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Catalent Pharma Main Business
Table 99. Catalent Pharma Latest Developments
Table 100. Catalent Pharma Basic Information, Company Total Revenue (in $ million), Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 101. Huadong Pharmaceutical Product Offered
Table 102. Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. Huadong Pharmaceutical Main Business
Table 104. Huadong Pharmaceutical Latest Developments
Table 105. Huadong Pharmaceutical Basic Information, Company Total Revenue (in $ million), Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 106. Genzyme Product Offered
Table 107. Genzyme Basic Information, Company Total Revenue (in $ million), Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 108. Genzyme Main Business
Table 109. Genzyme Latest Developments
Table 110. Genzyme Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. Cinkate Corporation Product Offered
Table 112. Cinkate Corporation Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Cinkate Corporation Main Business
Table 114. Cinkate Corporation Latest Developments
Table 115. Cinkate Corporation Basic Information, Company Total Revenue (in $ million), Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 116. Changzhou Pharm Product Offered
Table 117. Changzhou Pharm Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 118. Changzhou Pharm Main Business
Table 119. Changzhou Pharm Latest Developments
Table 120. Changzhou Pharm Basic Information, Company Total Revenue (in $ million), Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 121. Cilag Product Offered
Table 122. Cilag Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 123. Cilag Main Business
Table 124. Cilag Latest Developments
Table 125. Cilag Basic Information, Company Total Revenue (in $ million), Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 126. SL PHARM Product Offered
Table 127. SL PHARM Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 128. SL PHARM Main Business
Table 129. SL PHARM Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. SL PHARM Latest Developments
Table 131. Sirio Pharma Co., Ltd Product Offered
Table 132. Sirio Pharma Co., Ltd Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 133. Sirio Pharma Co., Ltd Main Business
Table 134. Sirio Pharma Co., Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. Sirio Pharma Co., Ltd Latest Developments
Table 136. Livzon Pharmaceutical Group Inc., Product Offered
Table 137. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 138. Livzon Pharmaceutical Group Inc., Main Business
Table 139. Livzon Pharmaceutical Group Inc., Latest Developments
Table 140. Livzon Pharmaceutical Group Inc., Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Organ Transplant Immunosuppressant
Figure 2. Organ Transplant Immunosuppressant Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Organ Transplant Immunosuppressant Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Organ Transplant Immunosuppressant Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Tacrolimus
Figure 7. Product Picture of Mycophenolate Mofetil
Figure 8. Product Picture of Cyclosporin
Figure 9. Product Picture of Others
Figure 10. Global Organ Transplant Immunosuppressant Consumption Market Share by Type (2015-2020)
Figure 11. Global Organ Transplant Immunosuppressant Value Market Share by Type (2015-2020)
Figure 12. Organ Transplant Immunosuppressant Consumed in Liver Transplant
Figure 13. Global Organ Transplant Immunosuppressant Market: Liver Transplant (2015-2020) (K Units)
Figure 14. Global Organ Transplant Immunosuppressant Market: Liver Transplant (2015-2020) ($ Millions)
Figure 15. Organ Transplant Immunosuppressant Consumed in Kidney Transplant
Figure 16. Global Organ Transplant Immunosuppressant Market: Kidney Transplant (2015-2020) (K Units)
Figure 17. Global Organ Transplant Immunosuppressant Market: Kidney Transplant (2015-2020) ($ Millions)
Figure 18. Organ Transplant Immunosuppressant Consumed in Heart Transplant
Figure 19. Global Organ Transplant Immunosuppressant Market: Heart Transplant (2015-2020) (K Units)
Figure 20. Global Organ Transplant Immunosuppressant Market: Heart Transplant (2015-2020) ($ Millions)
Figure 21. Organ Transplant Immunosuppressant Consumed in Other Organ Transplant
Figure 22. Global Organ Transplant Immunosuppressant Market: Other Organ Transplant (2015-2020) (K Units)
Figure 23. Global Organ Transplant Immunosuppressant Market: Other Organ Transplant (2015-2020) ($ Millions)
Figure 24. Global Organ Transplant Immunosuppressant Consumption Market Share by Application (2015-2020)
Figure 25. Global Organ Transplant Immunosuppressant Value Market Share by Application (2015-2020)
Figure 26. Global Organ Transplant Immunosuppressant Sales Market Share by Company in 2017
Figure 27. Global Organ Transplant Immunosuppressant Sales Market Share by Company in 2019
Figure 28. Global Organ Transplant Immunosuppressant Revenue Market Share by Company in 2017
Figure 29. Global Organ Transplant Immunosuppressant Revenue Market Share by Company in 2019
Figure 30. Global Organ Transplant Immunosuppressant Sale Price by Company in 2019
Figure 31. Global Organ Transplant Immunosuppressant Consumption Market Share by Regions 2015-2020
Figure 32. Global Organ Transplant Immunosuppressant Value Market Share by Regions 2015-2020
Figure 33. Americas Organ Transplant Immunosuppressant Consumption 2015-2020 (K Units)
Figure 34. Americas Organ Transplant Immunosuppressant Value 2015-2020 ($ Millions)
Figure 35. APAC Organ Transplant Immunosuppressant Consumption 2015-2020 (K Units)
Figure 36. APAC Organ Transplant Immunosuppressant Value 2015-2020 ($ Millions)
Figure 37. Europe Organ Transplant Immunosuppressant Consumption 2015-2020 (K Units)
Figure 38. Europe Organ Transplant Immunosuppressant Value 2015-2020 ($ Millions)
Figure 39. Middle East & Africa Organ Transplant Immunosuppressant Consumption 2015-2020 (K Units)
Figure 40. Middle East & Africa Organ Transplant Immunosuppressant Value 2015-2020 ($ Millions)
Figure 41. Americas Organ Transplant Immunosuppressant Consumption Market Share by Countries in 2019
Figure 42. Americas Organ Transplant Immunosuppressant Value Market Share by Countries in 2019
Figure 43. Americas Organ Transplant Immunosuppressant Consumption Market Share by Type in 2019
Figure 44. Americas Organ Transplant Immunosuppressant Consumption Market Share by Application in 2019
Figure 45. United States Organ Transplant Immunosuppressant Consumption Growth 2015-2020 (K Units)
Figure 46. United States Organ Transplant Immunosuppressant Value Growth 2015-2020 ($ Millions)
Figure 47. Canada Organ Transplant Immunosuppressant Consumption Growth 2015-2020 (K Units)
Figure 48. Canada Organ Transplant Immunosuppressant Value Growth 2015-2020 ($ Millions)
Figure 49. Mexico Organ Transplant Immunosuppressant Consumption Growth 2015-2020 (K Units)
Figure 50. Mexico Organ Transplant Immunosuppressant Value Growth 2015-2020 ($ Millions)
Figure 51. APAC Organ Transplant Immunosuppressant Consumption Market Share by Countries in 2019
Figure 52. APAC Organ Transplant Immunosuppressant Value Market Share by Regions in 2019
Figure 53. APAC Organ Transplant Immunosuppressant Consumption Market Share by Type in 2019
Figure 54. APAC Organ Transplant Immunosuppressant Consumption Market Share by Application in 2019
Figure 55. China Organ Transplant Immunosuppressant Consumption Growth 2015-2020 (K Units)
Figure 56. China Organ Transplant Immunosuppressant Value Growth 2015-2020 ($ Millions)
Figure 57. Japan Organ Transplant Immunosuppressant Consumption Growth 2015-2020 (K Units)
Figure 58. Japan Organ Transplant Immunosuppressant Value Growth 2015-2020 ($ Millions)
Figure 59. Korea Organ Transplant Immunosuppressant Consumption Growth 2015-2020 (K Units)
Figure 60. Korea Organ Transplant Immunosuppressant Value Growth 2015-2020 ($ Millions)
Figure 61. Southeast Asia Organ Transplant Immunosuppressant Consumption Growth 2015-2020 (K Units)
Figure 62. Southeast Asia Organ Transplant Immunosuppressant Value Growth 2015-2020 ($ Millions)
Figure 63. India Organ Transplant Immunosuppressant Consumption Growth 2015-2020 (K Units)
Figure 64. India Organ Transplant Immunosuppressant Value Growth 2015-2020 ($ Millions)
Figure 65. Australia Organ Transplant Immunosuppressant Consumption Growth 2015-2020 (K Units)
Figure 66. Australia Organ Transplant Immunosuppressant Value Growth 2015-2020 ($ Millions)
Figure 67. Europe Organ Transplant Immunosuppressant Consumption Market Share by Countries in 2019
Figure 68. Europe Organ Transplant Immunosuppressant Value Market Share by Countries in 2019
Figure 69. Europe Organ Transplant Immunosuppressant Consumption Market Share by Type in 2019
Figure 70. Europe Organ Transplant Immunosuppressant Consumption Market Share by Application in 2019
Figure 71. Germany Organ Transplant Immunosuppressant Consumption Growth 2015-2020 (K Units)
Figure 72. Germany Organ Transplant Immunosuppressant Value Growth 2015-2020 ($ Millions)
Figure 73. France Organ Transplant Immunosuppressant Consumption Growth 2015-2020 (K Units)
Figure 74. France Organ Transplant Immunosuppressant Value Growth 2015-2020 ($ Millions)
Figure 75. UK Organ Transplant Immunosuppressant Consumption Growth 2015-2020 (K Units)
Figure 76. UK Organ Transplant Immunosuppressant Value Growth 2015-2020 ($ Millions)
Figure 77. Italy Organ Transplant Immunosuppressant Consumption Growth 2015-2020 (K Units)
Figure 78. Italy Organ Transplant Immunosuppressant Value Growth 2015-2020 ($ Millions)
Figure 79. Russia Organ Transplant Immunosuppressant Consumption Growth 2015-2020 (K Units)
Figure 80. Russia Organ Transplant Immunosuppressant Value Growth 2015-2020 ($ Millions)
Figure 81. Middle East & Africa Organ Transplant Immunosuppressant Consumption Market Share by Countries in 2019
Figure 82. Middle East & Africa Organ Transplant Immunosuppressant Value Market Share by Countries in 2019
Figure 83. Middle East & Africa Organ Transplant Immunosuppressant Consumption Market Share by Type in 2019
Figure 84. Middle East & Africa Organ Transplant Immunosuppressant Consumption Market Share by Application in 2019
Figure 85. Egypt Organ Transplant Immunosuppressant Consumption Growth 2015-2020 (K Units)
Figure 86. Egypt Organ Transplant Immunosuppressant Value Growth 2015-2020 ($ Millions)
Figure 87. South Africa Organ Transplant Immunosuppressant Consumption Growth 2015-2020 (K Units)
Figure 88. South Africa Organ Transplant Immunosuppressant Value Growth 2015-2020 ($ Millions)
Figure 89. Israel Organ Transplant Immunosuppressant Consumption Growth 2015-2020 (K Units)
Figure 90. Israel Organ Transplant Immunosuppressant Value Growth 2015-2020 ($ Millions)
Figure 91. Turkey Organ Transplant Immunosuppressant Consumption Growth 2015-2020 (K Units)
Figure 92. Turkey Organ Transplant Immunosuppressant Value Growth 2015-2020 ($ Millions)
Figure 93. GCC Countries Organ Transplant Immunosuppressant Consumption Growth 2015-2020 (K Units)
Figure 94. GCC Countries Organ Transplant Immunosuppressant Value Growth 2015-2020 ($ Millions)
Figure 95. Global Organ Transplant Immunosuppressant Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 96. Global Organ Transplant Immunosuppressant Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 97. Americas Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 98. Americas Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 99. APAC Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 100. APAC Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 101. Europe Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 102. Europe Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 103. Middle East & Africa Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 104. Middle East & Africa Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 105. United States Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 106. United States Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 107. Canada Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 108. Canada Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 109. Mexico Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 110. Mexico Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 111. Brazil Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 112. Brazil Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 113. China Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 114. China Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 115. Japan Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 116. Japan Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 117. Korea Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 118. Korea Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 119. Southeast Asia Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 120. Southeast Asia Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 121. India Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 122. India Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 123. Australia Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 124. Australia Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 125. Germany Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 126. Germany Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 127. France Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 128. France Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 129. UK Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 130. UK Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 131. Italy Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 132. Italy Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 133. Russia Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 134. Russia Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 135. Spain Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 136. Spain Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 137. Egypt Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 138. Egypt Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 139. South Africa Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 140. South Africa Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 141. Israel Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 142. Israel Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 143. Turkey Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 144. Turkey Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 145. GCC Countries Organ Transplant Immunosuppressant Consumption 2021-2025 (K Units)
Figure 146. GCC Countries Organ Transplant Immunosuppressant Value 2021-2025 ($ Millions)
Figure 147. Roche Organ Transplant Immunosuppressant Market Share (2018-2020)
Figure 148. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Market Share (2018-2020)
Figure 149. Astellas Pharma Inc. Organ Transplant Immunosuppressant Market Share (2018-2020)
Figure 150. Novartis Organ Transplant Immunosuppressant Market Share (2018-2020)
Figure 151. Catalent Pharma Organ Transplant Immunosuppressant Market Share (2018-2020)
Figure 152. Huadong Pharmaceutical Organ Transplant Immunosuppressant Market Share (2018-2020)
Figure 153. Genzyme Organ Transplant Immunosuppressant Market Share (2018-2020)
Figure 154. Cinkate Corporation Organ Transplant Immunosuppressant Market Share (2018-2020)
Figure 155. Changzhou Pharm Organ Transplant Immunosuppressant Market Share (2018-2020)
Figure 156. Cilag Organ Transplant Immunosuppressant Market Share (2018-2020)
Figure 157. SL PHARM Organ Transplant Immunosuppressant Market Share (2018-2020)
Figure 158. Sirio Pharma Co., Ltd Organ Transplant Immunosuppressant Market Share (2018-2020)
Figure 159. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets